CD274 and non-small cell lung carcinoma: Moreover, higher PD-L1 staining percentage by immunohistochemistry (IHC) in tumor cells has been associated with better efficacy of anti-PD-1/anti-PD-L1 antibodies in some tumors, such as non-small cell lung cancer (19).